Business Context and Reporting Period
This Form 8-K filing by Healthcare Trust of America, Inc. (referred to as Healthcare Realty Trust Inc in metadata) is dated July 8, 2016. The report discloses the approval of new employment agreements for four senior executives by the Compensation Committee of the Board of Directors.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation structures, including base salaries, bonus targets, equity grants, and severance provisions.
Material Changes
The primary material change is the execution of new employment contracts for the following officers, replacing or updating prior arrangements:
- Scott D. Peters (CEO/President): New 4-year term with a base salary of $900,000. Target annual bonus is 200% of base salary. Received a grant of 150,000 restricted shares vesting over four years. Annual equity award target value is 300% of base salary.
- Robert A. Milligan (CFO): New 4-year term with a base salary of $400,000. Target annual bonus is 100% of base salary. Received a restricted stock grant valued at $400,000 (vesting in one installment after 4 years) and a $100,000 performance bonus.
- Mark D. Engstrom (EVP-Acquisitions): New 3-year term with a base salary of $375,000. Target annual bonus is 100% of base salary.
- Amanda L. Houghton (EVP-Asset Management): New 2-year term with a base salary of $300,000. Target annual bonus is 100% of base salary.
Guidance, Outlook, and Risks
The filing contains no financial guidance or outlook. Key risks and contingencies relate to executive retention and severance liabilities:
- Severance for CEO: Upon termination without cause or for good reason, Mr. Peters is entitled to a lump sum equal to three times the sum of his base salary and target bonus, plus full vesting of unvested equity and up to 18 months of COBRA reimbursement.
- Severance for Other Executives: Upon similar termination, Messrs. Milligan and Engstrom and Ms. Houghton are entitled to a lump sum equal to two times their base salary, plus full vesting of unvested equity and up to 6 months of COBRA reimbursement.
- Restrictive Covenants: All agreements include non-solicitation covenants for one year post-termination. Non-competition covenants may apply for one year, requiring the Company to pay 60% (75% for Mr. Peters) of the sum of base salary and prior year bonus if enforced.
Investor Verification Checklist
- Verify the total cost of the new equity grants (150,000 shares for CEO and $400,000 value for CFO) against the company's current share price and treasury stock availability.
- Assess the potential maximum severance liability for the CEO (3x salary + bonus) versus the other executives (2x salary) in the event of a change in control or termination.
- Review the specific performance metrics defined by the Compensation Committee for the annual incentive bonuses, as these are not detailed in this filing.
- Confirm the impact of the non-competition payment obligations (60-75% of compensation) if the company elects to enforce these covenants.